225 related articles for article (PubMed ID: 22493351)
21. [Expression of PTEN in athymic mice with HCC treated by complex prescription of Chinese crude drug].
Sun BG; Chen ZX; Zhang SJ; Liu YD; Huang HZ; Yin LR
Zhongguo Zhong Yao Za Zhi; 2007 Jun; 32(11):1057-60. PubMed ID: 17672343
[TBL] [Abstract][Full Text] [Related]
22. Inhibitory effects of ganoderma lucidum on tumorigenesis and metastasis of human hepatoma cells in cells and animal models.
Weng CJ; Chau CF; Yen GC; Liao JW; Chen DH; Chen KD
J Agric Food Chem; 2009 Jun; 57(11):5049-57. PubMed ID: 19422227
[TBL] [Abstract][Full Text] [Related]
23. Human mesenchymal stem cells inhibit metastasis of a hepatocellular carcinoma model using the MHCC97-H cell line.
Li GC; Ye QH; Xue YH; Sun HJ; Zhou HJ; Ren N; Jia HL; Shi J; Wu JC; Dai C; Dong QZ; Qin LX
Cancer Sci; 2010 Dec; 101(12):2546-53. PubMed ID: 20942864
[TBL] [Abstract][Full Text] [Related]
24. Suppression of vascular endothelial growth factor via inactivation of eukaryotic elongation factor 2 by alkaloids in Coptidis rhizome in hepatocellular carcinoma.
Tan HY; Wang N; Tsao SW; Zhang Z; Feng Y
Integr Cancer Ther; 2014 Sep; 13(5):425-34. PubMed ID: 24363282
[TBL] [Abstract][Full Text] [Related]
25. [Chaiqiyigan granula enhances Taxol-induced growth inhibition of hepatocellular carcinoma xenografts in nude mice: an in vivo fluorescence imaging study].
You M; Luo M; Liao W; Hu S; Xu W; Jing L
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Jun; 32(7):1042-5. PubMed ID: 22820595
[TBL] [Abstract][Full Text] [Related]
26. Both antiangiogenesis- and angiogenesis-independent effects are responsible for hepatocellular carcinoma growth arrest by tyrosine kinase inhibitor PTK787/ZK222584.
Liu Y; Poon RT; Li Q; Kok TW; Lau C; Fan ST
Cancer Res; 2005 May; 65(9):3691-9. PubMed ID: 15867364
[TBL] [Abstract][Full Text] [Related]
27. [Effect of thalidomide on tumor growth in mouse hepatoma H22 model].
Zhai Y; Lu ZJ
Ai Zheng; 2003 Dec; 22(12):1301-6. PubMed ID: 14693056
[TBL] [Abstract][Full Text] [Related]
28. [Changes of metastatic potential of residual hepatocellular carcinoma in nude mice after in vivo chemotherapy and the corresponding mechanisms].
Xiong W; Tang ZY; Ren ZG; Zhu XD; Liu L; Zhang W; Wang WQ
Zhonghua Zhong Liu Za Zhi; 2012 Nov; 34(11):805-9. PubMed ID: 23291126
[TBL] [Abstract][Full Text] [Related]
29. Residual hepatocellular carcinoma after oxaliplatin treatment has increased metastatic potential in a nude mouse model and is attenuated by Songyou Yin.
Xiong W; Ren ZG; Qiu SJ; Sun HC; Wang L; Liu BB; Li QS; Zhang W; Zhu XD; Liu L; Wang WQ; Tang ZY
BMC Cancer; 2010 May; 10():219. PubMed ID: 20487542
[TBL] [Abstract][Full Text] [Related]
30. [Effects of sirolimus on the growth of transplanted hepatocellular carcinoma].
Zhang J; Li H; Wang GS; Jiang N; Yang Y; Chen GH
Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):413-6. PubMed ID: 19567017
[TBL] [Abstract][Full Text] [Related]
31. (-)-Epigallocatechin gallate suppresses the growth of human hepatocellular carcinoma cells by inhibiting activation of the vascular endothelial growth factor-vascular endothelial growth factor receptor axis.
Shirakami Y; Shimizu M; Adachi S; Sakai H; Nakagawa T; Yasuda Y; Tsurumi H; Hara Y; Moriwaki H
Cancer Sci; 2009 Oct; 100(10):1957-62. PubMed ID: 19558547
[TBL] [Abstract][Full Text] [Related]
32. EphA1 receptor silencing by small interfering RNA has antiangiogenic and antitumor efficacy in hepatocellular carcinoma.
Chen G; Wang Y; Zhou M; Shi H; Yu Z; Zhu Y; Yu F
Oncol Rep; 2010 Feb; 23(2):563-70. PubMed ID: 20043122
[TBL] [Abstract][Full Text] [Related]
33. Foretinib demonstrates anti-tumor activity and improves overall survival in preclinical models of hepatocellular carcinoma.
Huynh H; Ong R; Soo KC
Angiogenesis; 2012 Mar; 15(1):59-70. PubMed ID: 22187171
[TBL] [Abstract][Full Text] [Related]
34. Percutaneous intratumoral injection of traditional Chinese herbal compound medicine Star-99 in treatment of hepatocellular carcinoma of mice.
Lin LW; Sun Y; He YM; Gao SD; Xue ES; Lin XD; Yu LY; Lin XF; Yang YH
Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):49-54. PubMed ID: 14969837
[TBL] [Abstract][Full Text] [Related]
35. Autophagy activation in hepatocellular carcinoma contributes to the tolerance of oxaliplatin via reactive oxygen species modulation.
Ding ZB; Hui B; Shi YH; Zhou J; Peng YF; Gu CY; Yang H; Shi GM; Ke AW; Wang XY; Song K; Dai Z; Shen YH; Fan J
Clin Cancer Res; 2011 Oct; 17(19):6229-38. PubMed ID: 21825039
[TBL] [Abstract][Full Text] [Related]
36. Effect of rapamycin alone and in combination with sorafenib in an orthotopic model of human hepatocellular carcinoma.
Wang Z; Zhou J; Fan J; Qiu SJ; Yu Y; Huang XW; Tang ZY
Clin Cancer Res; 2008 Aug; 14(16):5124-30. PubMed ID: 18698030
[TBL] [Abstract][Full Text] [Related]
37. Regulation of angiogenesis by Id-1 through hypoxia-inducible factor-1alpha-mediated vascular endothelial growth factor up-regulation in hepatocellular carcinoma.
Lee TK; Poon RT; Yuen AP; Ling MT; Wang XH; Wong YC; Guan XY; Man K; Tang ZY; Fan ST
Clin Cancer Res; 2006 Dec; 12(23):6910-9. PubMed ID: 17145808
[TBL] [Abstract][Full Text] [Related]
38. Celastrus orbiculatus Thunb. ameliorates high-fat diet-induced non-alcoholic fatty liver disease in guinea pigs.
Zhang Y; Si Y; Zhai L; Yang N; Yao S; Sang H; Zu D; Xu X; Qin S; Wang J
Pharmazie; 2013 Oct; 68(10):850-4. PubMed ID: 24273892
[TBL] [Abstract][Full Text] [Related]
39. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.
Li Y; Yu DC; Chen Y; Amin P; Zhang H; Nguyen N; Henderson DR
Cancer Res; 2001 Sep; 61(17):6428-36. PubMed ID: 11522637
[TBL] [Abstract][Full Text] [Related]
40. Antitumor effect of vascular endothelial growth factor inhibitor sunitinib in preclinical models of hepatocellular carcinoma.
Bagi CM; Gebhard DF; Andresen CJ
Eur J Gastroenterol Hepatol; 2012 May; 24(5):563-74. PubMed ID: 22314934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
